Tonic-Clonic Seizures Treatment Market Trends There is a growing trend towards the use of combination therapies to manage tonic-clonic seizures. Combining multiple anti-seizure medications or ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated ...
LONDON, June 05, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in ...
-- New approval for VIMPAT® (lacosamide) CV in the U.S. as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older -- All three ...
Eisai announced results from a Phase 3 Study 332 trial of perampanel, an AMPA receptor antagonist in patients with primary generalized tonic-clonic (PGTC) seizures. Study 332 was a double-blind, ...
This page lists all known medications that could potentially lead to 'Tonic-clonic seizures' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
WASHINGTON -- Technologies to provide instant at-home detection of life-threatening seizures and that could allow epilepsy patients to monitor their own drug levels are on the horizon, researchers ...
Levetiracetam reduces tonic-clonic seizures by over 77% in clinical studies. Ethosuximide is highly effective for absence seizures, especially in children. Valproate remains the gold standard for ...
Researchers have discovered supplementing a normal, carbohydrate-rich diet with specific ketogenic agents may significantly delay tonic-clonic seizures caused by exposure to high levels of oxygen. The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. DENVER — Primary generalized tonic-clonic seizures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback